loading

Finanzdaten der Arcturus Therapeutics Holdings Inc-Aktie (ARCT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
58.04%
7.196
17.15 28.30 29.38 22.77
Operating Expenses
14.38%
38.50
33.66 39.92 46.21 56.16
Benefits Costs and Expenses
18.56%
36.28
30.60 37.48 43.46 52.77
Costs And Expenses
18.56%
36.28
30.60 37.48 43.46 52.77
Depreciation and Amortization
14.75%
0.682
0.80 0.80 0.801 0.819
Operating Income/Loss
89.60%
-31.31
-16.51 -11.62 -16.83 -33.39
Income/Loss From Continuing Operations Before Tax
116.26%
-29.08
-13.45 -9.176 -14.08 -30.01
Income/Loss From Continuing Operations After Tax
116.23%
-29.08
-13.45 -9.18 -14.08 -30.00
Net Income/Loss
116.23%
-29.08
-13.45 -9.18 -14.08 -30.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.10%
0.244
27.19 27.13 27.11 0.03
Diluted Average Shares
99.10%
0.244
27.19 27.13 27.11 0.03
Basic Earnings Per Share
114.29%
-1.05
-0.49 -0.34 -0.52 -1.11
Diluted Earnings Per Share
114.29%
-1.05
-0.49 -0.34 -0.52 -1.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.87
price up icon 0.18%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$139.44
price down icon 0.28%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):